M. Rodriguez

发表

A phase II and pharmacokinetic study of weekly 72-h topotecan infusion in patients with platinum-resistant and paclitaxel-resistant ovarian carcinoma.

C. Hoppel, P. Rose, S. Ingalls, 2000, Gynecologic oncology.

Liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a retrospective comparative study of single-agent dosages.

P. Rose, N. Fusco, M. Rodríguez, 2001, Gynecologic oncology.

Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma.

P. Rose, N. Fusco, L. Fluellen, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study.

L. Adler, F. Abdul-Karim, P. Rose, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer.

R. Angioli, R. Estape, H. Averette, 1999, American journal of obstetrics and gynecology.

Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone

T. Witzig, T. Habermann, M. Rodriguez, 1999, Medical oncology.

Tolerance of twenty-four hour paclitaxel and carboplatin as first-line therapy in ovarian, peritoneal and fallopian tube carcinoma.

P. Rose, N. Fusco, L. Fluellen, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Paclitaxel: a radiation sensitizer of human cervical cancer cells.

B. Sevin, H. Averette, C. Pham, 1995, Gynecologic oncology.

Ovarian tumor development: insights from ovarian embryogenesis.

L. Dubeau, M. Rodriguez, 2001, European journal of gynaecological oncology.

Radical abdominal trachelectomy and pelvic lymphadenectomy with uterine conservation and subsequent pregnancy in the treatment of early invasive cervical cancer.

P. Rose, M. Rodríguez, O. Guimares, 2002, American journal of obstetrics and gynecology.

Phase I study of paclitaxel, carboplatin, and increasing days of prolonged oral etoposide in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study.

S. Waggoner, P. Rose, I. Horowitz, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved therapeutic index of lower dose topotecan chemotherapy in recurrent ovarian cancer.

P. Rose, M. Rodríguez, Michael Rodriguez, 2001, Gynecologic oncology.

Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma.

B. Sangro, J. Quiroga, F. Rotellar, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Growth characteristics of nonmalignant cells in the ATP cell viability assay.

R. Angioli, B. Sevin, H. Averette, 1994, Oncology.

Malignant mixed mullerian tumor of the female peritoneum: treatment and outcome of three cases.

F. Abdul-Karim, P. Rose, M. Rodríguez, 1997, Gynecologic oncology.

A preliminary report of a phase II study of weekly topotecan in platinum-sensitive recurrent ovarian and peritoneal carcinoma.

M. Method, G. Lewandowski, L. Vaccarello, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.